市場調査レポート

商品コード

欧州の細胞・遺伝子治療市場の2031年までの予測 - 地域別分析、タイプ別、サービス別、規模別、サービスプロバイダー別、エンドユーザー別

Europe Cell and Gene Therapy Market Forecast to 2031 - Regional Analysis - by Type, Services, Scale, Service Providers, and End User

出版日: 2025年04月14日
発行: The Insight Partners
ページ情報: 英文 163 Pages
納期: 即納可能

価格

PDF (Single User License)

USD 3,450 512,221円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 4,450 660,691円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 5,450 809,161円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.47円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

欧州の細胞・遺伝子治療市場は、2023年に11億510万米ドルと評価され、2031年には53億3,444万米ドルに達すると予測され、2023年から2031年までの市場推計・予測CAGRは21.7%です。

細胞・遺伝子治療製造アウトソーシングの急速な普及が欧州の細胞・遺伝子治療市場を牽引

細胞・遺伝子治療製造は複雑なプロセスであるため、業務の適切な遂行と監視が極めて重要です。細胞・遺伝子治療メーカーは、生物学やプロセス工学に精通した有資格者の数が限られています。さらに、経験豊富なチームにとって、手作業でオープンな製造方法を用いて最初の臨床試験に到達する試みを管理することや、より商業的に適したプロセスを構築することは、困難なことです。そのため、これらのメーカーは、臨床試験と商業化プロセスを加速するために、開発・製造受託機関（CDMO）との協力を選択します。CDMOは、細胞・遺伝子治療企業に対して、製品開発、製造、臨床試験、商業化サービスを受託ベースでサポートしています。CDMOとのパートナーシップのもと、細胞・遺伝子治療メーカーは、スケーラビリティ、市場へのスピード、オーバーヘッドコストのない技術的専門知識へのアクセス、コスト効率をサポートします。細胞・遺伝子治療薬の製造をCDMOに委託することは、メーカーにとって費用対効果が高いです。製造業者はCDMOの技術的に高度なインフラと専門知識を利用することができます。CDMOは、細胞・遺伝子治療薬の製造に適切でマッピングされたプロセスを採用しています。このように、CDMOへの細胞・遺伝子治療製造のアウトソーシング志向の高まりが、欧州の細胞・遺伝子治療市場の成長を後押ししています。

欧州の細胞・遺伝子治療市場概要

ドイツの細胞・遺伝子治療市場は、生産能力構築への投資、政府の高い支援、同地域への関与などの要因により、予測期間中に大きな成長が見込まれます。また、競合上位企業の存在も、予測期間中の同地域市場の成長を高めると思われます。ドイツは強力な製薬産業を有し、研究開発への注力は顕著です。同国には660社のバイオテクノロジー企業があり、5万人の従業員を雇用しています。このうち660社が細胞・遺伝子治療（CGT）に注力しています。NecstGenの報告書によると、2023年には29以上のCAR改変免疫細胞を評価する活発な臨床試験が進行中であり、そのほとんどはCAR-T細胞に関するものでした。また、ドイツではこれまでに50以上の遺伝子治療の臨床試験が実施されています。ドイツのCGT企業は国際的なプレゼンスがないため、技術革新への取り組みは主に地域または国レベルに集中しています。

欧州の細胞・遺伝子治療市場のセグメンテーション

欧州の細胞・遺伝子治療市場は、タイプ、サービス、規模、エンドユーザー、国に分類されます。

タイプ別に見ると、欧州の細胞・遺伝子治療市場は細胞治療と遺伝子治療に二分されます。2023年には、細胞療法分野がより大きな市場シェアを占めています。さらに、細胞療法セグメントは同種、自家、ウイルスベクターに細分化されます。さらに、遺伝子治療セグメントは非ウイルスベクターとウイルスベクターに分けられます。

サービスの面では、欧州の細胞・遺伝子治療市場はプロセス開発、cGMP製造、レギュラトリーサービス、バイオアッセイサービスに分類されます。2023年にはプロセス開発分野が最大の市場シェアを占めています。

規模別では、欧州の細胞・遺伝子治療市場はプレコマーシャル/R&D製造とコマーシャルスケール製造に二分されます。2023年には、プレコマーシャル/R&D製造セグメントがより大きな市場シェアを占めました。

エンドユーザー別に見ると、欧州の細胞・遺伝子治療市場は、契約研究機関、製薬・バイオ製薬企業、学術・研究機関に区分されます。2023年には製薬・バイオ製薬企業セグメントが最大の市場シェアを占めました。

国別では、欧州の細胞・遺伝子治療市場は、英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。2023年の欧州の細胞・遺伝子治療市場シェアはドイツが独占しました。

Catalent Inc、Cell and Gene Therapy Catapult、Charles River Laboratories International Inc、F. Hoffmann-La Roche Ltd、FUJIFILM Holdings Corp、Lonza Group AG、Lotte Corp、Merck KGaA、Takara Bio Inc、Thermo Fisher Scientific Inc、WuXi AppTec Co Ltdは、欧州の細胞・遺伝子治療市場で事業を展開する主要企業です。

細胞・遺伝子治療市場：主要市場力学
市場促進要因
- 細胞・遺伝子治療の承認件数の増加
- 細胞・遺伝子治療製造のアウトソーシングの急速な普及
市場抑制要因
- 細胞・遺伝子治療製造の高コスト
市場機会
- 企業による戦略的取り組み
今後の動向
- 細胞・遺伝子治療製造サービスの自動化
促進要因と抑制要因の影響

第6章細胞・遺伝子治療市場：欧州市場分析

欧州の概要
欧州の細胞・遺伝子治療市場収益、2021～2031年
欧州の細胞・遺伝子治療市場予測分析

第7章欧州の細胞・遺伝子治療市場分析：タイプ別

細胞療法
遺伝子治療

第8章欧州の細胞・遺伝子治療市場分析：サービス別

プロセス開発
cGMP製造
薬事サービス
バイオアッセイサービス

第9章欧州の細胞・遺伝子治療市場分析：規模別

プレコマーシャル/R&D製造
商業スケール製造

第10章欧州の細胞・遺伝子治療市場分析：サービスプロバイダー別

CDMO
CMOs

第11章欧州の細胞・遺伝子治療市場分析：エンドユーザー別

契約研究機関
製薬・バイオ製薬企業
学術・研究機関

第12章欧州の細胞・遺伝子治療市場：国別分析

英国
ドイツ
フランス
イタリア
スペイン
その他欧州

第13章業界情勢

細胞・遺伝子治療市場における成長戦略
有機的成長戦略
無機的成長戦略

第14章企業プロファイル

Thermo Fisher Scientific Inc.
Merck KGaA
Charles River Laboratories International Inc
Cell and Gene Therapy Catapult
Lonza Group AG
WuXi AppTec Co Ltd
Takara Bio Inc
FUJIFILM Holdings Corp
F. Hoffmann-La Roche Ltd
Catalent Inc
Lotte Corp

第15章付録

図表

List Of Tables

Table 1. Cell and Gene Therapy Market Segmentation
Table 2. Europe Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 4. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Cell Therapy
Table 5. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Gene Therapy
Table 6. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Services
Table 7. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Scale
Table 8. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Service Providers
Table 9. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 10. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 11. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 12. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 13. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 14. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 15. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 16. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 17. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 18. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 19. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 20. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 21. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 22. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 23. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 24. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 25. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 26. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 27. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 28. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 29. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 30. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 31. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 32. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 33. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 34. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 35. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 36. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 37. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 38. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 39. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 40. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 41. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 42. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 43. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 44. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 45. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 46. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 47. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
Table 48. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
Table 49. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 50. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
Table 51. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
Table 52. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 53. Recent Organic Growth Strategies in Cell and Gene Therapy Market
Table 54. Recent Inorganic Growth Strategies in the Cell and Gene Therapy Market
Table 55. Glossary of Terms

List Of Figures

Figure 1. Cell and Gene Therapy Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
Figure 5. Cell and Gene Therapy Market Share (%) - by Type (2023 and 2031)
Figure 6. Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Cell and Gene Therapy Market Share (%) - by Services (2023 and 2031)
Figure 9. Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Cell and Gene Therapy Market Share (%) - by Scale (2023 and 2031)
Figure 14. Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Cell and Gene Therapy Market Share (%) - by Service Providers (2023 and 2031)
Figure 17. CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Cell and Gene Therapy Market Share (%) - by End User (2023 and 2031)
Figure 20. Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Europe Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Europe Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 25. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 27. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 28. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 29. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 30. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
Figure 31. Growth Strategies in Cell and Gene Therapy Market

Product Code: BMIRE00031471

The Europe cell and gene therapy market was valued at US$ 1,105.10 million in 2023 and is projected to reach US$ 5,334.44 million by 2031; it is estimated to record a CAGR of 21.7% from 2023 to 2031.

Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing Drives Europe Cell and Gene Therapy Market

Cell and gene therapy manufacturing is a complex process, which makes the proper execution and monitoring of the operation crucial. Cell and gene therapy manufacturers have a limited number of qualified personnel who know biological and process engineering. Moreover, for experienced teams, managing the attempts to reach the first clinical trial using a manual and open manufacturing method, as well as building a more commercially suitable process, can be challenging. Therefore, these manufacturers choose to work with contract development and manufacturing organizations (CDMOs) to accelerate their clinical studies and commercialization process. CDMOs support product development, manufacturing, clinical trials, and commercialization services to cell and gene therapy companies on a contract basis. Under the partnership with a CDMO, cell and gene therapy manufacturers support scalability, speed to market, access to technical expertise without overhead costs, and cost efficiencies. Outsourcing cell and gene therapy manufacturing to CDMOs proves to be cost-effective for manufacturers. They gain access to the technologically advanced infrastructure and expertise of CDMOs. CDMOs employ proper, mapped processes for manufacturing cell and gene therapies. Thus, the increasing preference for outsourcing growing cell and gene therapy manufacturing to CDMOs fuels the Europe cell and gene therapy market growth.

Europe Cell and Gene Therapy Market Overview

The cell and gene therapy market in Germany is expected to witness significant growth during the forecast period due to factors such as investment in the setup of production capacity, high government support, and involvement in the region. Also, the presence of top competitive players will enhance the regional market growth during the forecast period. Germany has a strong pharmaceutical industry with a notable focus on R&D. The country has 660 biotechnology companies that employ 50,000 employees. Among these, 660 companies are focused on cell and gene therapies (CGTs). As per the NecstGen report, more than 29 active clinical trials evaluating CAR-modified immune cells were ongoing in 2023, and most of the production involved CAR-T cells. Also, over 50 clinical studies have been conducted in gene therapy in Germany so far. The innovation efforts of German CGT companies are majorly focused on the local or country level, as they lack international presence.

Europe Cell and Gene Therapy Market Revenue and Forecast to 2031 (US$ Million)

Europe Cell and Gene Therapy Market Segmentation

The Europe cell and gene therapy market is categorized into type, services, scale, end user, and country.

Based on type, the Europe cell and gene therapy market is bifurcated into cell therapy and gene therapy. The cell therapy segment held a larger market share in 2023. Furthermore, the cell therapy segment is sub segmented into allogeneic, autologous, viral vectors. Additionally, the gene therapy segment is divided into non-viral vectors and viral vectors.

In terms of services, the Europe cell and gene therapy market is categorized process development, cGMP manufacturing, regulatory services, and bioassay services. The process development segment held the largest market share in 2023.

By scale, the Europe cell and gene therapy market is bifurcated into pre-commercial/R&D manufacturing and commercial scale manufacturing. The pre-commercial/R&D manufacturing segment held a larger market share in 2023.

Based on end user, the Europe cell and gene therapy market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, and academic and research institutes. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2023.

By country, the Europe cell and gene therapy market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe cell and gene therapy market share in 2023.

Catalent Inc, Cell and Gene Therapy Catapult, Charles River Laboratories International Inc, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corp, Lonza Group AG, Lotte Corp, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc., and WuXi AppTec Co Ltd are some of the leading companies operating in the Europe cell and gene therapy market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Europe Cell and Gene Therapy Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Europe Cell and Gene Therapy Market - Key Market Dynamics

5.1 Cell and Gene Therapy Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increase in Number of Approval of Cell and Gene Therapies
- 5.2.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.3 Market Restraints
- 5.3.1 High Cost of Cell and Gene Therapy Manufacturing
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Companies
5.5 Future Trends
- 5.5.1 Automation of Cell and Gene Therapy Manufacturing Services
5.6 Impact of Drivers and Restraints:

6. Cell and Gene Therapy Market -Europe Market Analysis

6.1 Overview Europe
6.2 Europe Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
6.3 Europe Cell and Gene Therapy Market Forecast Analysis

7. Europe Cell and Gene Therapy Market Analysis - by Type

7.1 Cell Therapy
- 7.1.1 Overview
- 7.1.2 Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
- 7.2.1 Overview
- 7.2.2 Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Cell and Gene Therapy Market Analysis - by Services

8.1 Process Development
- 8.1.1 Overview
- 8.1.2 Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.2 cGMP Manufacturing
- 8.2.1 Overview
- 8.2.2 cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Regulatory Services
- 8.3.1 Overview
- 8.3.2 Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Bioassay Services
- 8.4.1 Overview
- 8.4.2 Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Cell and Gene Therapy Market Analysis - by Scale

9.1 Pre-Commercial/R&D Manufacturing
- 9.1.1 Overview
- 9.1.2 Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Commercial Scale Manufacturing
- 9.2.1 Overview
- 9.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Cell and Gene Therapy Market Analysis - by Service Providers

10.1 CDMOs
- 10.1.1 Overview
- 10.1.2 CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
10.2 CMOs
- 10.2.1 Overview
- 10.2.2 CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

11. Europe Cell and Gene Therapy Market Analysis - by End User

11.1 Contract Research Organizations
- 11.1.1 Overview
- 11.1.2 Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Pharmaceutical and Biopharmaceutical Companies
- 11.2.1 Overview
- 11.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Academic and Research Institutes
- 11.3.1 Overview
- 11.3.2 Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

12. Europe Cell and Gene Therapy Market - Country Analysis

12.1 Europe Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.1.1 Europe Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.1.1.1 Europe Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.1.1.2 United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.2.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Type
      - 12.1.1.2.1.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Cell Therapy
      - 12.1.1.2.1.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.1.1.2.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Services
    - 12.1.1.2.3 United Kingdom: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.1.1.2.4 United Kingdom: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.1.1.2.5 United Kingdom: Cell and Gene Therapy Market Breakdown, by End User
  - 12.1.1.3 Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.3.1 Germany: Cell and Gene Therapy Market Breakdown, by Type
      - 12.1.1.3.1.1 Germany: Cell and Gene Therapy Market Breakdown, by Cell Therapy
      - 12.1.1.3.1.2 Germany: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.1.1.3.2 Germany: Cell and Gene Therapy Market Breakdown, by Services
    - 12.1.1.3.3 Germany: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.1.1.3.4 Germany: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.1.1.3.5 Germany: Cell and Gene Therapy Market Breakdown, by End User
  - 12.1.1.4 France: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.4.1 France: Cell and Gene Therapy Market Breakdown, by Type
      - 12.1.1.4.1.1 France: Cell and Gene Therapy Market Breakdown, by Cell Therapy
      - 12.1.1.4.1.2 France: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.1.1.4.2 France: Cell and Gene Therapy Market Breakdown, by Services
    - 12.1.1.4.3 France: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.1.1.4.4 France: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.1.1.4.5 France: Cell and Gene Therapy Market Breakdown, by End User
  - 12.1.1.5 Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.5.1 Italy: Cell and Gene Therapy Market Breakdown, by Type
      - 12.1.1.5.1.1 Italy: Cell and Gene Therapy Market Breakdown, by Cell Therapy
      - 12.1.1.5.1.2 Italy: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.1.1.5.2 Italy: Cell and Gene Therapy Market Breakdown, by Services
    - 12.1.1.5.3 Italy: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.1.1.5.4 Italy: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.1.1.5.5 Italy: Cell and Gene Therapy Market Breakdown, by End User
  - 12.1.1.6 Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.6.1 Spain: Cell and Gene Therapy Market Breakdown, by Type
      - 12.1.1.6.1.1 Spain: Cell and Gene Therapy Market Breakdown, by Cell Therapy
      - 12.1.1.6.1.2 Spain: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.1.1.6.2 Spain: Cell and Gene Therapy Market Breakdown, by Services
    - 12.1.1.6.3 Spain: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.1.1.6.4 Spain: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.1.1.6.5 Spain: Cell and Gene Therapy Market Breakdown, by End User
  - 12.1.1.7 Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.7.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Type
      - 12.1.1.7.1.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Cell Therapy
      - 12.1.1.7.1.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.1.1.7.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Services
    - 12.1.1.7.3 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.1.1.7.4 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.1.1.7.5 Rest of Europe: Cell and Gene Therapy Market Breakdown, by End User

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in Cell and Gene Therapy Market
13.3 Organic Growth Strategies
- 13.3.1 Overview
13.4 Inorganic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Thermo Fisher Scientific Inc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Merck KGaA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Charles River Laboratories International Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Cell and Gene Therapy Catapult
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Lonza Group AG
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 WuXi AppTec Co Ltd
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Takara Bio Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 FUJIFILM Holdings Corp
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 F. Hoffmann-La Roche Ltd
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Catalent Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Lotte Corp
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms

欧州の細胞・遺伝子治療市場の2031年までの予測 - 地域別分析、タイプ別、サービス別、規模別、サービスプロバイダー別、エンドユーザー別

Europe Cell and Gene Therapy Market Forecast to 2031 - Regional Analysis - by Type, Services, Scale, Service Providers, and End User

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章欧州の細胞・遺伝子治療市場情勢

第5章欧州の細胞・遺伝子治療市場：主要市場力学

第6章細胞・遺伝子治療市場：欧州市場分析

第7章欧州の細胞・遺伝子治療市場分析：タイプ別

第8章欧州の細胞・遺伝子治療市場分析：サービス別

第9章欧州の細胞・遺伝子治療市場分析：規模別

第10章欧州の細胞・遺伝子治療市場分析：サービスプロバイダー別

第11章欧州の細胞・遺伝子治療市場分析：エンドユーザー別

第12章欧州の細胞・遺伝子治療市場：国別分析

第13章業界情勢

第14章企業プロファイル

第15章付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Europe Cell and Gene Therapy Market Landscape

5. Europe Cell and Gene Therapy Market - Key Market Dynamics

6. Cell and Gene Therapy Market -Europe Market Analysis

7. Europe Cell and Gene Therapy Market Analysis - by Type

8. Europe Cell and Gene Therapy Market Analysis - by Services

9. Europe Cell and Gene Therapy Market Analysis - by Scale

10. Europe Cell and Gene Therapy Market Analysis - by Service Providers

11. Europe Cell and Gene Therapy Market Analysis - by End User

12. Europe Cell and Gene Therapy Market - Country Analysis

13. Industry Landscape

14. Company Profiles

15. Appendix

欧州の細胞・遺伝子治療市場の2031年までの予測 - 地域別分析、タイプ別、サービス別、規模別、サービスプロバイダー別、エンドユーザー別

Europe Cell and Gene Therapy Market Forecast to 2031 - Regional Analysis - by Type, Services, Scale, Service Providers, and End User

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 欧州の細胞・遺伝子治療市場情勢

第5章 欧州の細胞・遺伝子治療市場：主要市場力学

第6章 細胞・遺伝子治療市場：欧州市場分析

第7章 欧州の細胞・遺伝子治療市場分析：タイプ別

第8章 欧州の細胞・遺伝子治療市場分析：サービス別

第9章 欧州の細胞・遺伝子治療市場分析：規模別

第10章 欧州の細胞・遺伝子治療市場分析：サービスプロバイダー別

第11章 欧州の細胞・遺伝子治療市場分析：エンドユーザー別

第12章 欧州の細胞・遺伝子治療市場：国別分析

第13章 業界情勢

第14章 企業プロファイル

第15章 付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Europe Cell and Gene Therapy Market Landscape

5. Europe Cell and Gene Therapy Market - Key Market Dynamics

6. Cell and Gene Therapy Market -Europe Market Analysis

7. Europe Cell and Gene Therapy Market Analysis - by Type

8. Europe Cell and Gene Therapy Market Analysis - by Services

9. Europe Cell and Gene Therapy Market Analysis - by Scale

10. Europe Cell and Gene Therapy Market Analysis - by Service Providers

11. Europe Cell and Gene Therapy Market Analysis - by End User

12. Europe Cell and Gene Therapy Market - Country Analysis

13. Industry Landscape

14. Company Profiles

15. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章欧州の細胞・遺伝子治療市場情勢

第5章欧州の細胞・遺伝子治療市場：主要市場力学

第6章細胞・遺伝子治療市場：欧州市場分析

第7章欧州の細胞・遺伝子治療市場分析：タイプ別

第8章欧州の細胞・遺伝子治療市場分析：サービス別

第9章欧州の細胞・遺伝子治療市場分析：規模別

第10章欧州の細胞・遺伝子治療市場分析：サービスプロバイダー別

第11章欧州の細胞・遺伝子治療市場分析：エンドユーザー別

第12章欧州の細胞・遺伝子治療市場：国別分析

第13章業界情勢

第14章企業プロファイル

第15章付録